
Risultati per 'Biontex':
Di seguito l'elenco dei risultati di ricerca trovati rilevanti per la keyword 'Biontex':
Risultati maggiormente rilevanti:


Biontex Homepage (EN) with navigation to shop, products, technology, contact, support, free sample offer, transfection reagent selection guide, news Your region: America. Your region: America. Menu Search. Account. Cart 0. Recently added item(s) You have no items in your shopping cart. Search: Search. My ...


METAFECTENE® is a liposome-based transfection reagent composed of a mixture of polycationic and neutral lipids, which enables efficient levels to be reached in DNA transfection of most mammalian cells. In addition, low cytotoxicity and freedom from serum inhibition make it suitable for a wide range of uses. In comparison with first-generation transfection (e.g. DOTAP) reagents reagents of the ...


Con questa Vision il Brand Biotex® è diventato il riferimento della traspirazione e protezione delle performance sportive. Biotex® nasce nel 1990 da un’intuizione di Antonio Visani, che mettendo a frutto 30 di artigianato di altissima qualità ha voluto fin da subito migliorare il mondo del ciclismo che lo ha sempre circondato.
Altri risultati:


We are committed to improving the health of people worldwide with our fundamental research and development of immunotherapies. We believe in scientific rigor, innovation and passion as driving force. BioNTech was founded by scientists and physicians to translate science into survival by combining fundamental research and operational excellence.


BioNTech's founding place and global headquarters is Mainz, Germany, where the COVID-19 vaccine was created.The company runs multiple sites in the country. Further research locations are in San Diego and Cambridge, Massachusetts, the latter of which also serves as the North American headquarters. Additionally the company owns GMP-certified production facilities in Idar-Oberstein, Martinsried ...


Ultimo prezzo oggi: 149,61 Azioni BioNTech (NASDAQ: BNTX) in Borsa in tempo reale. Scopri andamento, quotazione e valore azionario del titolo BioNTech.


MAINZ, GERMANY, December 21, 2022 — BioNTech SE (Nasdaq: BNTX, “BioNTech”) reached the next milestone in the establishment of scalable mRNA vaccine production in Africa. The six ISO-sized shipping containers for the first BioNTainer have finished construction in Europe, underwent quality checks by BioNTech experts and are being prepared ...